InfoBionic Receives CE Mark for MoMe System

InfoBionic Inc., an emerging digital health company, has received the CE Mark for its MoMe system for cardiac arrhythmia monitoring.

The MoMe system, according to the Lowell, Mass.-based firm, is a universal remote patient-monitoring platform with seamless transition between Holter, Event, and Mobile Cardiac Telemetry (MCT) modes. The platform leverages Cloud computing and proprietary analytics to deliver on-demand access to patient data for diagnosis.

“We are pleased to receive CE Mark for the MoMe system. We believe the system will transform the arrhythmia monitoring market by offering superior arrhythmia detection and favorable physician practice economics,” CEO Nancy Briefs said. “We look forward to commercializing our first product for cardiac arrhythmia monitoring in early 2014.”

The MoMe Ssystem draws on the recent convergence of medical devices, database analytics, new sensors, and wireless protocols to provide a universal patient monitoring platform complete with real-time, high-quality patient data for improved arrhythmia detection.  

“Existing cardiac patient monitoring systems have significant limitations, including poor data quality and limited data availability,” said Liviu Klein, M.D., UCSF Heart and Vascular Center. “The MoMe system provides high-quality data and real-time rhythm history as well as activity, respiration and symptom tracking that allows me to make a fast, accurate, timely and efficient medical diagnosis.”